Chemokine (C-C Motif) Ligand 18 (Pulmonary and Activation-Regulated) (CCL18) ELISA试剂盒

CCL18 is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. 再加上,我们可以发CCL18 抗体 (46)CCL18 蛋白 (41)和数多这个蛋白质的别的产品。

list all ELISA KIts 基因 基因ID UniProt
CCL18 6362 P55774
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • 在线下订单

antibodies-online.cn销售最多的CCL18 ELISA试剂盒

Showing 3 out of 5 products:

产品编号 适用 灵敏度 范围 图像 规格 交付 价格 详细
Human CCL18/PARC Accusignal ELISA Kit Human CCL18/PARC AccuSignal ELISA Kit standard curve. Assay Range: 7.8pg/ml-500pg/ml. Sensitivity:  1 kit 1至2个工作日
< 1.875 ng/mL 3.125 ng/mL - 200 ng/mL   100 Tests 2至3个工作日
46.875 pg/mL 78.125 pg/mL - 5000 pg/mL   96 Tests 11至18个工作日

适于 CCL18 相互作用对的更多 ELISA 试剂盒

Human Chemokine (C-C Motif) Ligand 18 (Pulmonary and Activation-Regulated) (CCL18) interaction partners

  1. High serum levels of the CCL18 is associated with non-small cell lung cancer.

  2. KL-6 but not CCL-18 is predictive of early systemic sclerosis -related interstitial lung disease progression.

  3. these findings indicate that the CCL18/PITPNM3/NF-kB/VCAM-1 regulatory network might provide a potential new therapeutic strategy for pancreatic ductal adenocarcinoma.

  4. ARF6 GTPase-activating protein ACAP4 regulates CCL18-elicited breast cancer cell migration via the acetyltransferase PCAF-mediated acetylation. CCL18 stimulation elicited breast cancer cell migration and invasion via PCAF-dependent acetylation.

  5. We have found that CCL18 is highly expressed in glioma tissues and enhances the invasion, migration, and proliferation of U251 glioma cells. Therefore, CCL18 may be a potential biomarker for detecting and grading human glioma.

  6. In patients with breast cancer who received anthracycline-containing NAC the absence of clinical response is associated with the presence of M2+ macrophage phenotype (YKL-39-CCL18 + or YKL-39 + CCL18-) based on TOP2a overexpression data.

  7. CCL18 secreted from M2 macrophages had the same effect on GBC cells as M2 macrophages.

  8. Blocking CCR8 via a small molecule inhibitor or short hairpin (sh)RNA mitigated the decrease in Ecadherin, and increase in MMP2 and VEGFC, caused by human recombinant (r)CCL18. CCR8 knockdown by shRNA reversed rCCL18induced cancer cell invasion, migration and epithelialmesenchymal transition

  9. CCL18 has a role in the progression of urothelial carcinoma, especially in recipients of renal transplants

  10. miR-128 interacts with CCL18 3'UTR, reducing its expression in malignant melanoma.

  11. AMAP1 mediated CCL18-induce activation of NF-kappaB and promoted breast cancer metastasis.

  12. results of the study indicate that there could be a relationship between the expression of CCL-18 in nasal turbinate mucosa and the severity of allergic rhinitis

  13. chemokine CCL18 can be a mediator of peritoneal membrane failure associated with peritonitis episodes as well as providing a new potential therapeutic target.

  14. CCL18 was up-regulated in diffuse large B cell lymphoma and related to poor prognosis

  15. Serum C-C motif chemokine ligand 18 (CCL18) was elevated in patients with epithelial ovarian cancer (EOC) and could serve as a new tumor biomarker, which also predicted a poor survival of the patient.

  16. In advanced lung adenocarcinoma, infiltration of CCL18(+) tumor-associated macrophages (TAMs) was increased and higher expression of CCL18 by TAMs was associated with a favorable prognosis in lymph-node positive NSCLC

  17. This study study discovered a positive feedback loop between CTGF and CCL18 in hepatocellular carcinoma metastasis.

  18. All patients with NPC1 mutations had high ChT activity, high CCL18/PARC concentrations and/or Niemann-Pick disease type C suspicion index scores >/=70.

  19. findings suggest that these pulmonary markers could be useful to assess CAP severity and, especially YKL-40 and CCL18 by helping predict CAP caused by atypical pathogens

  20. PARC activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.

CCL18 抗原简介

Antigen Summary

This gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for naive T cells, CD4+ and CD8+ T cells and nonactivated lymphocytes, but not for monocytes or granulocytes. This chemokine attracts naive T lymphocytes toward dendritic cells and activated macrophages in lymph nodes. It may play a role in both humoral and cell-mediated immunity responses.

Gene names and symbols associated with CCL18

  • C-C motif chemokine ligand 18 (CCL18) 抗体
  • AMAC-1 抗体
  • AMAC1 抗体
  • CKb7 抗体
  • DC-CK1 抗体
  • DCCK1 抗体
  • MIP-4 抗体
  • PARC 抗体
  • SCYA18 抗体

Protein level used designations for CCL18

C-C motif chemokine 18 , CC chemokine PARC , CC chemokine ligand 18 , alternative macrophage activation-associated CC chemokine 1 , chemokine (C-C), dendritic , dendritic cell chemokine 1 , macrophage inflammatory protein 4 , pulmonary and activation-regulated chemokine , small inducible cytokine A18 , small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary and activation-regulated , small-inducible cytokine A18 , chemokine CCL18/PARC

6362 Homo sapiens
574181 Macaca mulatta
CCL18 (CCL18) ELISA试剂盒 精选生产商